Theralase(R) Extends Warrants
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Theralase Technologies Inc. (TLT)
Theralase Technologies Inc. stock price live, this page displays TSXV TLT stock exchange data. View the TLT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Theralase Technologies Inc. real time stock price chart below.
What Is the Theralase Technologies Inc. Stock Price Today?
The Theralase Technologies Inc. stock price today is 0.220.
What Is the Stock Symbol for Theralase Technologies Inc.?
The stock symbol for Theralase Technologies Inc. is ""TLT.""
What Stock Exchange Does Theralase Technologies Inc. Trade On?
Theralase Technologies Inc. is listed and trades on the TSXV stock exchange.
Is Theralase Technologies Inc. a Good Stock to Buy?
Determining whether Theralase Technologies Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLT quote. (ISIN: CA88337V1004)
What Is the Theralase Technologies Inc. Stock Price Today?
The Theralase Technologies Inc. stock price today is 0.220.
What Is the Stock Symbol for Theralase Technologies Inc.?
The stock symbol for Theralase Technologies Inc. is ""TLT.""
What Stock Exchange Does Theralase Technologies Inc. Trade On?
Theralase Technologies Inc. is listed and trades on the TSXV stock exchange.
Is Theralase Technologies Inc. a Good Stock to Buy?
Determining whether Theralase Technologies Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLT quote. (ISIN: CA88337V1004)
0.220
+0.005(+2.33%)
Closed·
Fair Value
An estimate of a Theralase Technologies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.210
0.220
52 wk Range
0.155
0.380
TLT Scorecard
Full Analysis
Net income is expected to grow this year
TLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Theralase Technologies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2100.220
52 wk Range
0.1550.380
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
TLT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Theralase Technologies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
0.700
Upside
+218.18%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Theralase(R) 1Q2025 Financial Statements
- Investing.com
- Theralase(R) Closes Non-Brokered Private Placement
- Investing.com
- Theralase(R) Extends Warrants
- Investing.com
- Theralase(R) Closes Non-Brokered Private Placement
- Investing.com
- Theralase Annual General Meeting
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Theralase Technologies Inc. Company Profile
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Theralase Technologies Inc. Earnings Call Summary for Q1/2025
- Theralase Technologies missed Q1 2025 forecasts with EPS of -0.006 and revenue of $91,190, leading to a 9.52% stock drop to $0.19
- Revenue declined to $91,000 from $175,000 YoY, with increased operating expenses in administration and R&D
- Company aims to complete clinical studies, targeting FDA and Health Canada applications by Q4 2026 and potential approval in early 2027
- CEO emphasized focus on light-activated therapeutics, highlighting Ruvedar's efficacy and pursuing debt financing to reduce dilution
- Financial challenges persist, with $8-10 million needed for clinical studies and efforts to secure non-dilutive funding ongoing
Last Updated: 09/06/2025, 16:48
Read Full TranscriptCompare TLT to Peers and Sector
Metrics to compare | TLT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTLTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.2x | −4.9x | −0.6x | |
PEG Ratio | −1.20 | −0.08 | 0.00 | |
Price/Book | 44.3x | 0.0x | 2.6x | |
Price / LTM Sales | 53.0x | 11.6x | 3.3x | |
Upside (Analyst Target) | 218.2% | 579.4% | 39.1% | |
Fair Value Upside | Unlock | −4.9% | 5.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.700
(+218.18% Upside)
Earnings
Latest Release
Aug 26, 2025
EPS / Forecast
-0.004 / -0.003
Revenue / Forecast
219.74K / 200.00K
FAQ
What Stock Exchange Does Theralase Technologies Trade On?
Theralase Technologies is listed and trades on the TSX Venture Exchange stock exchange.
What Is the Stock Symbol for Theralase Technologies?
The stock symbol for Theralase Technologies is "TLT."
What Is the Theralase Technologies Market Cap?
As of today, Theralase Technologies market cap is 15.54M.
What Is Theralase Technologies's Earnings Per Share (TTM)?
The Theralase Technologies EPS (TTM) is -0.02.
When Is the Next Theralase Technologies Earnings Date?
Theralase Technologies will release its next earnings report on 25 Nov 2025.
From a Technical Analysis Perspective, Is TLT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Theralase Technologies Stock Split?
Theralase Technologies has split 0 times.
How Many Employees Does Theralase Technologies Have?
Theralase Technologies has 20 employees.
What is the current trading status of Theralase Technologies (TLT)?
As of 29 Aug 2025, Theralase Technologies (TLT) is trading at a price of 0.220, with a previous close of 0.22. The stock has fluctuated within a day range of 0.210 to 0.220, while its 52-week range spans from 0.155 to 0.380.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.